- Home
- COP vs BSX Comparison
COP vs BSX Comparison
Compare COP & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COP
- BSX
- Stock Information
- Founded
- COP 1917
- BSX 1979
- Country
- COP United States
- BSX United States
- Employees
- COP N/A
- BSX N/A
- Industry
- COP Integrated oil Companies
- BSX Medical/Dental Instruments
- Sector
- COP Energy
- BSX Health Care
- Exchange
- COP Nasdaq
- BSX Nasdaq
- Market Cap
- COP 119.9B
- BSX 138.4B
- IPO Year
- COP N/A
- BSX 1992
- Fundamental
- Price
- COP $95.57
- BSX $103.19
- Analyst Decision
- COP Buy
- BSX Strong Buy
- Analyst Count
- COP 18
- BSX 22
- Target Price
- COP $120.06
- BSX $112.86
- AVG Volume (30 Days)
- COP 8.9M
- BSX 7.4M
- Earning Date
- COP 08-07-2025
- BSX 07-23-2025
- Dividend Yield
- COP 3.27%
- BSX N/A
- EPS Growth
- COP N/A
- BSX 15.23
- EPS
- COP 7.91
- BSX 1.37
- Revenue
- COP $59,090,000,000.00
- BSX $17,554,000,000.00
- Revenue This Year
- COP $7.63
- BSX $17.50
- Revenue Next Year
- COP $1.76
- BSX $10.75
- P/E Ratio
- COP $12.08
- BSX $75.30
- Revenue Growth
- COP 4.00
- BSX 19.36
- 52 Week Low
- COP $79.88
- BSX $71.88
- 52 Week High
- COP $118.40
- BSX $107.53
- Technical
- Relative Strength Index (RSI)
- COP 58.68
- BSX 49.67
- Support Level
- COP $93.20
- BSX $101.56
- Resistance Level
- COP $96.92
- BSX $104.41
- Average True Range (ATR)
- COP 2.28
- BSX 1.83
- MACD
- COP 0.32
- BSX -0.11
- Stochastic Oscillator
- COP 83.37
- BSX 34.54
About COP ConocoPhillips
ConocoPhillips is a US-based independent exploration and production firm. In 2024, it produced 2.0 million barrels per day of oil and natural gas liquids and 3.4 billion cubic feet per day of natural gas, primarily from Alaska and the Lower 48 in the United States and Norway in Europe and several countries in Asia-Pacific and the Middle East. Proven reserves at year-end 2024 were 7.8 billion barrels of oil equivalent.
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.